Search bioRxiv⌕ Search

Biology subjects

Hastie, J. L.

Publications and source records attributed to Hastie, J. L..

2 recordsLinked to original sources

Clostridioides difficile utilizes siderophores as an iron source and FhuDBGC contributes to ferrichrome uptake

Clostridioides difficile remains a public health threat commonly observed following antibiotic use. Due to the importance of iron in many cell processes, most bacteria, including C. difficile, have multiple mechanisms of acquiring iron. Previous studies have examined ferrous iron uptake in C. difficile, here we focus on the role of siderophores. In a growth assay, we show that C. difficile can use a variety of siderophores as the sole iron source. In C. difficile, two ABC transporters induced under low iron conditions are predicted siderophore importers: FhuDBGC and YclNOPQ. We hypothesized that these transporters are responsible for the uptake of the siderophores we tested. To investigate the specificity of these transporters, we purified the substrate binding proteins and examined siderophore binding using thermal shift. We demonstrate increased stability between one siderophore binding protein, FhuD, and the siderophore ferrichrome, suggesting a binding interaction. This specificity correlates with the inability of an{Delta} fhuDBGC mutant to grow efficiently under iron limiting conditions in the presence of ferrichrome. While C. difficile used additional siderophores in our growth experiments, we did not observe increased thermal stability between the receptor proteins and any of the other siderophores tested, suggesting these siderophores do not bind these receptors and other siderophore import mechanisms remain to be elucidated. Redundancy in iron acquisition is a microbial survival adaptation to cope with the constant battle for iron within a host. Greater knowledge about how C. difficile acquires iron will provide insight about how C. difficile colonizes and persists in the colon. IMPORTANCEThis study is the first example of C. difficile growing with siderophores as the sole iron source and describes the characterization of the ferric hydroxamate uptake ABC transporter (FhuDBGC). This transporter shows specificity to the siderophore ferrichrome. While not required for pathogenesis, this transporter highlights the redundancy in iron acquisition mechanisms which C. difficile uses to compete for iron during an infection.

microbiology↗

Phage-specific immune responses impair efficacy of phage therapy targeting VRE in a murine model

Antimicrobial resistant bacteria are an emerging and prevalent global threat with an urgent need for alternative therapies. Bacteriophage (phage) therapy is a promising approach to address these infections that has gained renewed interest in recent years. Despite this, questions remain regarding the therapeutic use of phages, including the impact that the immune response may have on phage therapy, particularly when this treatment is administered long-term or when reusing a specific phage treatment in a single individual. To investigate this, we developed a mouse model to assess phage treatment using a cocktail of five phages from the Myoviridae and Siphoviridae families that target vancomycin-resistant enterococcus (VRE) gut colonization. Phage cocktail treatment significantly reduced the intestinal bacterial burden of VRE in mice. We characterized innate and adaptive immune responses elicited against the phage cocktail after one and multiple exposures, respectively. While minimal innate responses were observed after phage administration, two courses of phage therapy induced phage-specific neutralizing antibodies and appeared to accelerate phage clearance from tissues. Interestingly, the myophages in our cocktail induced a more robust neutralizing antibody response than the siphophages. Proteins targeted by phage-specific antibodies were also identified from each phage family of the cocktail. Importantly, we show that this anti-phage immunity reduced the effectiveness of the phage cocktail in our murine model, leading to significantly higher fecal bacterial burden following repeat treatment. Collectively, this study shows the immune system has the potential to impede effectiveness of phage therapy and that the phage-specific immune responses can differ significantly between phages. These findings can help inform decisions about inclusion of specific phages in cocktails for future studies.

immunology↗